BiondVax Pharmaceuticals (BVXV) stock Forecast for 2022 – 2026
Last update: 05-17-2022, 14:23
Sector: HealthcareThe share price of BiondVax Pharmaceuticals Ltd. (BVXV) now
What analysts predict:: $9.5
52-week high/low: $4.19 / $1
50/200 Day Moving Average: $1.454 / $1.904
This figure corresponds to the average price over the previous 50/200 days. For BiondVax Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For BiondVax Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in BiondVax Pharmaceuticals Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BiondVax Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one BiondVax Pharmaceuticals share be worth in 2022 - 2026?
When should I take profit in BiondVax Pharmaceuticals stock? When should I record a loss on BiondVax Pharmaceuticals stock? What are analysts' forecasts for BiondVax Pharmaceuticals stock? What is the future of BiondVax Pharmaceuticals stock?
We forecast BiondVax Pharmaceuticals stock performance using neural networks based on historical data on BiondVax Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BiondVax Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BiondVax Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of BiondVax Pharmaceuticals stock
The chart below shows the historical price of BiondVax Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BiondVax Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
BiondVax Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 19 | 1.27 | 1.23 | 1.32 | 7.45 |
| May 20 | 1.23 | 1.19 | 1.27 | 7.36 |
| May 21 | 1.16 | 1.14 | 1.18 | 3.49 |
| May 22 | 1.18 | 1.12 | 1.22 | 8.88 |
| May 23 | 1.15 | 1.10 | 1.18 | 6.98 |
| May 24 | 1.23 | 1.18 | 1.27 | 7.34 |
| May 25 | 1.27 | 1.25 | 1.31 | 4.70 |
| May 26 | 1.29 | 1.25 | 1.31 | 5.15 |
| May 27 | 1.36 | 1.29 | 1.43 | 11.24 |
| May 28 | 1.30 | 1.25 | 1.31 | 5.07 |
| May 29 | 1.30 | 1.24 | 1.36 | 9.50 |
| May 30 | 1.31 | 1.25 | 1.36 | 8.82 |
| May 31 | 1.30 | 1.28 | 1.38 | 7.49 |
| Jun 01 | 1.39 | 1.37 | 1.42 | 3.48 |
| Jun 02 | 1.36 | 1.30 | 1.41 | 8.38 |
| Jun 03 | 1.41 | 1.33 | 1.48 | 11.05 |
| Jun 04 | 1.37 | 1.32 | 1.40 | 5.72 |
| Jun 05 | 1.45 | 1.38 | 1.51 | 9.34 |
| Jun 06 | 1.47 | 1.45 | 1.50 | 3.98 |
| Jun 07 | 1.47 | 1.43 | 1.54 | 7.33 |
| Jun 08 | 1.46 | 1.39 | 1.50 | 8.43 |
| Jun 09 | 1.48 | 1.45 | 1.53 | 6.01 |
| Jun 10 | 1.53 | 1.50 | 1.57 | 4.29 |
| Jun 11 | 1.51 | 1.46 | 1.55 | 5.70 |
| Jun 12 | 1.50 | 1.44 | 1.58 | 9.89 |
| Jun 13 | 1.58 | 1.52 | 1.63 | 7.81 |
| Jun 14 | 1.62 | 1.57 | 1.66 | 5.79 |
| Jun 15 | 1.55 | 1.50 | 1.59 | 5.98 |
| Jun 16 | 1.57 | 1.51 | 1.64 | 8.68 |
| Jun 17 | 1.62 | 1.55 | 1.65 | 6.61 |
BiondVax Pharmaceuticals Daily Price Targets
BiondVax Pharmaceuticals Stock Forecast 05-19-2022.
Pessimistic target level: 1.23
Optimistic target level: 1.32
BiondVax Pharmaceuticals Stock Forecast 05-20-2022.
Pessimistic target level: 1.19
Optimistic target level: 1.27
BiondVax Pharmaceuticals Stock Forecast 05-21-2022.
Pessimistic target level: 1.14
Optimistic target level: 1.18
BiondVax Pharmaceuticals Stock Forecast 05-22-2022.
Pessimistic target level: 1.12
Optimistic target level: 1.22
BiondVax Pharmaceuticals Stock Forecast 05-23-2022.
Pessimistic target level: 1.10
Optimistic target level: 1.18
BiondVax Pharmaceuticals Stock Forecast 05-24-2022.
Pessimistic target level: 1.18
Optimistic target level: 1.27
BVXV (BVXV) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 1.11 | 0.89 | 1.18 | 24.27 |
| Jul. | 1.05 | 0.97 | 1.12 | 13.64 |
| Aug. | 0.95 | 0.86 | 1.01 | 14.77 |
| Sep. | 1.04 | 0.87 | 1.21 | 27.77 |
| Oct. | 0.81 | 0.75 | 0.98 | 23.54 |
| Nov. | 1.02 | 0.93 | 1.24 | 24.53 |
| Dec. | 1.18 | 0.97 | 1.29 | 24.74 |
BiondVax Pharmaceuticals forecast for this year
BiondVax Pharmaceuticals Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $1.10836. Pessimistic: $0.89. Optimistic: $1.18
BiondVax Pharmaceuticals Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $1.0525. Pessimistic: $0.97. Optimistic: $1.12
BiondVax Pharmaceuticals Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $0.949354. Pessimistic: $0.86. Optimistic: $1.01
BiondVax Pharmaceuticals Stock Prediction for Sep 2022
An uptrend is forecast for this month with an optimal target price of $1.04239. Pessimistic: $0.87. Optimistic: $1.21
BiondVax Pharmaceuticals Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $0.814732. Pessimistic: $0.75. Optimistic: $0.98
BiondVax Pharmaceuticals Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $1.02233. Pessimistic: $0.93. Optimistic: $1.24
BiondVax Pharmaceuticals Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $1.1769. Pessimistic: $0.97. Optimistic: $1.29
BiondVax Pharmaceuticals (BVXV) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.31 | 1.21 | 1.41 | 14.24 |
| Feb | 1.22 | 0.99 | 1.47 | 32.70 |
| Mar | 1.23 | 1.08 | 1.33 | 19.11 |
| Apr | 1.15 | 1.05 | 1.25 | 15.93 |
| May | 1.00 | 0.85 | 1.21 | 29.65 |
| Jun | 0.92 | 0.79 | 1.03 | 23.36 |
| Jul | 0.91 | 0.85 | 1.11 | 23.56 |
| Aug | 1.14 | 1.07 | 1.34 | 20.61 |
| Sep | 1.19 | 0.98 | 1.40 | 29.92 |
| Oct | 1.11 | 0.89 | 1.27 | 29.40 |
| Nov | 1.01 | 0.90 | 1.19 | 24.22 |
| Dec | 1.09 | 0.98 | 1.17 | 16.62 |
BiondVax Pharmaceuticals (BVXV) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.17 | 1.06 | 1.35 | 21.30 |
| Feb | 1.21 | 0.97 | 1.28 | 24.66 |
| Mar | 1.26 | 1.09 | 1.36 | 19.99 |
| Apr | 1.33 | 1.05 | 1.57 | 33.24 |
| May | 1.59 | 1.28 | 1.85 | 30.83 |
| Jun | 1.73 | 1.41 | 2.11 | 33.32 |
| Jul | 1.84 | 1.46 | 2.03 | 28.23 |
| Aug | 2.26 | 2.10 | 2.74 | 23.32 |
| Sep | 2.12 | 1.90 | 2.52 | 24.76 |
| Oct | 1.68 | 1.41 | 1.95 | 27.94 |
| Nov | 1.45 | 1.33 | 1.73 | 22.94 |
| Dec | 1.36 | 1.21 | 1.47 | 17.57 |
BiondVax Pharmaceuticals (BVXV) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.49 | 1.30 | 1.67 | 21.85 |
| Feb | 1.40 | 1.11 | 1.50 | 26.36 |
| Mar | 1.57 | 1.35 | 1.90 | 28.83 |
| Apr | 1.59 | 1.34 | 1.76 | 23.79 |
| May | 1.55 | 1.38 | 1.88 | 26.61 |
| Jun | 1.53 | 1.20 | 1.77 | 31.95 |
| Jul | 1.54 | 1.28 | 1.80 | 28.77 |
| Aug | 1.62 | 1.25 | 1.77 | 29.15 |
| Sep | 1.32 | 1.03 | 1.47 | 30.31 |
| Oct | 1.35 | 1.13 | 1.58 | 28.46 |
| Nov | 1.25 | 1.03 | 1.38 | 25.44 |
| Dec | 1.22 | 1.10 | 1.46 | 24.40 |
BiondVax Pharmaceuticals (BVXV) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.07 | 0.85 | 1.22 | 30.38 |
| Feb | 1.37 | 1.23 | 1.52 | 18.88 |
| Mar | 1.40 | 1.27 | 1.63 | 21.92 |
| Apr | 1.53 | 1.19 | 1.71 | 30.66 |
| May | 1.63 | 1.29 | 1.91 | 32.52 |
| Jun | 1.99 | 1.64 | 2.32 | 29.08 |
| Jul | 1.85 | 1.67 | 2.02 | 16.96 |
| Aug | 1.95 | 1.55 | 2.31 | 33.09 |
| Sep | 1.58 | 1.35 | 1.69 | 20.36 |
| Oct | 1.63 | 1.50 | 1.91 | 21.28 |
| Nov | 1.53 | 1.42 | 1.85 | 23.19 |
| Dec | 1.28 | 1.18 | 1.37 | 13.83 |
BiondVax Pharmaceuticals information and performance
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company developing a universal influenza vaccine called M-001. BiondVax is a publicly traded company, listed on the NASDAQ. The vaccine technology was invented in the 1990s at the Weizmann Institute of Science in the laboratory of Ruth Arnon, and was licensed to BiondVax in 2003.
BiondVax Pharmaceuticals Address
JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, IL
Market Capitalization: 22 537 700 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: N/A
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -2.296
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: 2.825
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 18626200
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A